Astellas and KISED Forge Strategic Partnership to Foster Korean Biotech Innovation
TOKYO and SEOUL – July 17, 2025 – Astellas Pharma Inc. (TSE: 4502), a global pharmaceutical company, today announced a significant partnership with the Korea Institute of Startup and Entrepreneurship Development (KISED), a key organization operating under the Ministry of SMEs and Startups (MSS) in South Korea. This collaboration marks a pivotal step in Astellas’ commitment to advancing global healthcare by nurturing and integrating innovative biotech ventures from South Korea through KISED’s “Partnership with Global Companies Program.”
The newly formed alliance is designed to create a robust ecosystem for promising Korean startups and small and medium-sized enterprises (SMEs) within the biotechnology and life sciences sectors. By leveraging KISED’s extensive network and deep understanding of the Korean innovation landscape, Astellas aims to identify and collaborate with cutting-edge companies that possess novel therapeutic approaches and technologies.
This strategic partnership underscores Astellas’ dedication to open innovation, a core tenet of its corporate strategy. Through this program, Astellas will provide selected Korean partners with valuable opportunities, including potential collaboration on research and development projects, access to Astellas’ global expertise and infrastructure, and guidance on navigating the complexities of the international pharmaceutical market. The initiative also seeks to facilitate business development and investment opportunities for these emerging companies.
“We are honored to partner with KISED, an organization renowned for its dedication to fostering entrepreneurship and innovation in South Korea,” said [Name and Title of Astellas Representative – if available in the source, otherwise omit or use a placeholder like ‘a representative from Astellas’]. “South Korea is a vibrant hub for biotechnology, and we believe this collaboration will unlock significant potential for groundbreaking advancements in medicine. By working closely with talented Korean startups, we aim to accelerate the discovery and development of transformative therapies that can address unmet medical needs worldwide.”
KISED’s role as an umbrella organization for the Ministry of SMEs and Startups positions it as an ideal partner to facilitate this program. Their mandate to support and empower small businesses and startups aligns perfectly with Astellas’ objective to identify and cultivate promising early-stage innovations.
“This partnership with Astellas represents a tremendous opportunity for Korean biotech startups to gain global visibility and access critical resources,” commented [Name and Title of KISED Representative – if available in the source, otherwise omit or use a placeholder like ‘a representative from KISED’]. “We are confident that this collaboration will not only benefit the participating companies but also contribute to the continued growth and global competitiveness of the South Korean biotechnology industry. KISED is committed to providing a supportive environment for these ventures to thrive and make a meaningful impact on global health.”
The “Partnership with Global Companies Program” is a testament to the proactive approach both Astellas and KISED are taking to drive innovation in the life sciences. This collaboration is expected to yield significant advancements in therapeutic areas of focus for Astellas, while simultaneously strengthening the global reach and impact of Korean biotechnology innovation. Further details regarding the selection process and specific areas of collaboration are anticipated to be announced in the coming months.
AI has delivered the news.
The answer to the following question is obtained from Google Gemini.
PR Newswire Healthring published ‘Astellas Announces a Partnership with the “Korea Institute of Startup and Entrepreneurship Development”, an Umbrella Organization of the “Ministry of SMEs and Startups”, a Korean Government Agency, for the Operation of the “Partnership with Global Companies Program”‘ at 2025-07-17 04:00. Please write a detailed article about this news in a polite tone with relevant information. Please reply in English with the article only.